http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102128622-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2018-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102128622-B1 |
| titleOfInvention | Pharmaceutical composition comprising the extract of perilla leaf as an effective component for prevention or treatment of thrombosis and health functional food comprising the same |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating thrombosis and a health functional food containing a sesame leaf (Leaf of Perilla) extract as an active ingredient, and more specifically, a powerful blood using the sesame leaf extract as an active ingredient The present invention relates to a pharmaceutical composition for preventing or treating/improving thrombosis through coagulation inhibitory activity and a dietary supplement. The sesame leaf extract as an active ingredient in the pharmaceutical composition and health functional food for prevention or treatment/improvement of thrombosis of the present invention exhibits strong antithrombotic activity through inhibition of blood clotting factors and enzymes related to thrombosis, and also against human red blood cells. Since it does not show any hemolytic activity, has excellent thermal stability, and does not exhibit loss of blood clotting factor inhibitory effect and enzyme inhibitory effect related to thrombus production even in acidic conditions of pH 2 and plasma, such as ischemic stroke and hemorrhagic stroke It is expected to be used for the prevention and treatment of thrombosis, and the active ingredient is processed into various forms such as extract, powder, pill, tablet, etc., so it has an excellent effect that can be prepared in a form that can be taken at all times. It is a very useful invention in the industry. |
| priorityDate | 2018-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.